| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/27/2002 | US6441042 Hydroxamic acid derivatives as antibacterials |
| 08/27/2002 | US6441017 Inhibitors of prenyl-protein transferase |
| 08/27/2002 | US6441005 Oxazolidinone compounds and compositions, and methods of using the same |
| 08/27/2002 | US6440992 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof |
| 08/27/2002 | US6440991 Ethers of 7-desmethlrapamycin |
| 08/27/2002 | US6440990 O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants |
| 08/27/2002 | US6440985 Methods for treating viral infections |
| 08/27/2002 | US6440980 Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs |
| 08/27/2002 | US6440973 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents |
| 08/27/2002 | US6440971 Binuclear complex |
| 08/27/2002 | US6440966 Benzenesulfonamide derivatives and their use as MEK inhibitors |
| 08/27/2002 | US6440957 Cephalosporines having cyclic aminoguanidine substituents as antibiotics |
| 08/27/2002 | US6440942 Modifications to enhance acid stability and prevent anhydro formation; roxithromycin and clarithromycin; active against mls-resistant strains (mls=macrolides-lincosamides-streptogramines) |
| 08/27/2002 | US6440941 Derivatives of erythromycin, their preparation process and their use as medicaments |
| 08/27/2002 | US6440935 Such as cecropins and sarcotoxins |
| 08/27/2002 | US6440743 Supplying immobilizated polynucleotides |
| 08/27/2002 | US6440742 Recombinant AAV vector-based transduction system and use of same |
| 08/27/2002 | US6440736 Altering the properties of cells or of particles with membranes derived from cells by means of lipid-modified proteinaceous molecules |
| 08/27/2002 | US6440730 Retroviral hybrid vectors pseudotyped with LCMV |
| 08/27/2002 | US6440691 Melanins with improved ability to inhibit HIV replication |
| 08/27/2002 | US6440656 Methods for the inhibition of respiratory syncytial virus transmission |
| 08/27/2002 | US6440466 Composition for treating white spot syndrome virus (WSSV) infected tiger shrimp penaeus monodon and a process for preparation thereof |
| 08/27/2002 | US6440458 Solid solution of tacrolimus or hydrate and hydroxypropyl cellulose |
| 08/27/2002 | US6440426 Antigen-containing formulation and methods of use thereof |
| 08/27/2002 | US6440425 High molecular weight major outer membrane protein of moraxella |
| 08/27/2002 | US6440423 Mutant enterotoxin effective as a non-toxic oral adjuvant |
| 08/27/2002 | US6440422 Expressing foreign genes inserted at site of naturally occurring deletion in modified vaccinia virus ankara genome; polypeptides, e.g. antigens or therapeutic agents, or viral vectors for gene therapy; encoding antigens as vaccines |
| 08/27/2002 | US6440419 J chain or portion thereof linked to at least one enzyme inhibitor; specifically binds to basolateral factor; eradi-cation of metastatic or nonpolarized cells; lung, breast, colon, ovarian and prostate carcinoma and endometriosis |
| 08/27/2002 | US6440416 Primate antiidiotype antibody or fragment acting as immuno-genic functional mimic; preventive or therapeutic immune response against tumors, viruses, bacteria, rickettsia, mycoplasma, protozoa, fungi and multicellular parasites |
| 08/27/2002 | US6440413 Selectively destroying subunit a without destroying subunit b of cholera toxin; enzyme with preponderance of exocellular proteinase produced by a culture of streptomyces fradiae; hyperviscosity of intestinal, bronchial and/or genital mucus |
| 08/27/2002 | US6440409 Method for efficient and highly selective control of microorganisms |
| 08/27/2002 | US6440408 Method of treatment |
| 08/27/2002 | CA2224738C Use of ritonavir (abt-538) for improving the pharmacokinetics of drugs metabolized by cytochrome p450 in a method of treating aids |
| 08/27/2002 | CA2173939C Oligopeptides derived from c-reactive protein fragments |
| 08/27/2002 | CA2108898C Blended carboxylic acid sanitizer |
| 08/27/2002 | CA2085354C Ether lipid-nucleoside covalent conjugates |
| 08/27/2002 | CA2025703C Pulsatile once-a-day delivery systems for minocycline |
| 08/26/2002 | CA2373363A1 Antitumor and antiviral medications and method for producing the same |
| 08/22/2002 | WO2002065129A2 Epitopic sequences for diagnosing infection by chlamydia trachomatis |
| 08/22/2002 | WO2002064792A2 Molecules for disease detection and treatment |
| 08/22/2002 | WO2002064768A1 Method of screening inhibitor for the chromosomal segregation function of bacterium and inhibitor obtained by the screening method |
| 08/22/2002 | WO2002064766A2 Bax-responsive genes for drug target identification in yeast and fungi |
| 08/22/2002 | WO2002064757A2 Influenza viruses with enhanced transcriptional and replicational capacities |
| 08/22/2002 | WO2002064748A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 08/22/2002 | WO2002064731A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 08/22/2002 | WO2002064634A2 Human monoclonal antibodies to fc alpha receptor (cd89) |
| 08/22/2002 | WO2002064627A2 Crystallization of igf-1 |
| 08/22/2002 | WO2002064616A2 Agonists and antagonists of sphingosine-1-phosphate receptors |
| 08/22/2002 | WO2002064612A2 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 08/22/2002 | WO2002064607A1 12- and 13-modified novel 16-membered macrolide derivatives |
| 08/22/2002 | WO2002064587A1 Ratjadone derivatives for inhibiting cell growth |
| 08/22/2002 | WO2002064586A2 Heterocyclic inhibitors of erk2 and uses thereof |
| 08/22/2002 | WO2002064584A1 Phthalayinone-piperidino-derivatives as pde4 inhibitors |
| 08/22/2002 | WO2002064574A2 Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods |
| 08/22/2002 | WO2002064564A1 Benzo'f!isoindole derivatives with affinity to the ep4 receptor |
| 08/22/2002 | WO2002064552A1 1g(a)-AMINO-N-HYDROXY-ACETAMIDE DERIVATIVES |
| 08/22/2002 | WO2002064551A1 Hiv protease inhibitors based on amino acid derivatives |
| 08/22/2002 | WO2002064162A2 Vaccine for transcutaneous immunization |
| 08/22/2002 | WO2002064161A2 Method and compositions for immunization with the pseudomonas v antigen |
| 08/22/2002 | WO2002064154A2 Methods and compositions for inhibiting hiv-coreceptor interactions |
| 08/22/2002 | WO2002064151A1 Acrochordon alleviation |
| 08/22/2002 | WO2002064145A1 Thioxazinoquinolones useful for the treatment of viral infections |
| 08/22/2002 | WO2002064144A1 Aqueous suspension eyedrops and process for producing the same |
| 08/22/2002 | WO2002064138A1 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester |
| 08/22/2002 | WO2002064127A1 Methods and clinical devices for the inhibition or prevention of mammalian cell growth |
| 08/22/2002 | WO2002064089A2 Methods of preventing ventilator associated pneumonia by oral administration of antimicrobial ib-367 peptides |
| 08/22/2002 | WO2002064083A2 Synthesis of 3-amino-thalidomide and its enantiomers |
| 08/22/2002 | WO2002064082A2 Herbal medication for the improvement of aids patients |
| 08/22/2002 | WO2002064081A2 Herbal/medication for the improvement of aids patients |
| 08/22/2002 | WO2002045652A3 Tyrosine kinase inhibitors |
| 08/22/2002 | WO2002040021A3 Methods for inhibiting the transmission of hiv using topically applied substituted 6-benzyl-4-oxopyrimidines |
| 08/22/2002 | WO2002033050A3 Methods and compositions for promoting the maturation of monocytes |
| 08/22/2002 | WO2002032404A3 Nanoparticles |
| 08/22/2002 | WO2002024210A3 Halogen compounds for use in medicine |
| 08/22/2002 | WO2002023186A3 System and method for optimizing drug therapy for the treatment of diseases |
| 08/22/2002 | WO2002002755A3 Regulation of human thimet oligopeptidase-like enzyme |
| 08/22/2002 | WO2001087328A3 Interleukin-1 inhibitors in the treatment of diseases |
| 08/22/2002 | WO2001085204A3 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells |
| 08/22/2002 | WO2001085203A3 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells |
| 08/22/2002 | WO2000024907A9 Library of novel "unnatural" natural products |
| 08/22/2002 | WO2000023465A9 Methods and reagents for isolating biologically active peptides |
| 08/22/2002 | WO2000014200A9 Essential bacterial genes and their use |
| 08/22/2002 | WO1999058143A9 Utilization of interferon alpha 5 in the treatment of viral hepatopathies |
| 08/22/2002 | US20020116724 Nucleotide sequences codingolypeptide for use in the diagnosis and prevention of psoriasis and venous ulcers |
| 08/22/2002 | US20020115863 Hydroxamate derivatives that inhibit peptidyl deformylase (PDF), antimicrobials and antibiotics |
| 08/22/2002 | US20020115856 Selective cyclooxygenase-2 (COX-2) inhibitors; for example, 1-(5-Methanesulfonyl-pyridin-2-yl)-7-methoxy-3-trifluoromethyl-4,5-dihydro -1H-benzo(g)indazole |
| 08/22/2002 | US20020115852 7-(((5-Amino-1,2,4-thiadiazol-3-yl)-(Z)-(fluormethoxyimino) -acetyl)amino)-3(E)-((imino-1-piperazinylmethyl)-methylhydrazono)methyl-3 -cephem-4-carboxylic acid hydrochloride, for example |
| 08/22/2002 | US20020115843 Nucleotide sequences for use in the treatment of viral diseases, hypertension and coagulation defects |
| 08/22/2002 | US20020115835 Methods utilizing aryl thioimines in synthesis of erythromycin derivatives |
| 08/22/2002 | US20020115833 Glycoprotein for use in the treatment of kidney and blood disorders |
| 08/22/2002 | US20020115829 Pathogenic escherichia coli associated protein |
| 08/22/2002 | US20020115825 Peptide for use in the treatment of gastrointestinal inflammation and defects of the blood brain barrier |
| 08/22/2002 | US20020115690 Free of alcohol and propylene glycol; surfactant; polyethylene glycol solvent having a mean molecular weight of greater than 300 but lower than 600 |
| 08/22/2002 | US20020115650 Cephalosporin antibiotics and prodrugs thereof |
| 08/22/2002 | US20020115642 3-(2-(2,4-dichlorophenoxy)-5-chlorophenoxy)methyl-7-(2 -thienylacetamido)-3-cephem-4-carboxylic acid; for antibiotic (vancomycin) sensitive/resistant microorganisms |
| 08/22/2002 | US20020115624 Such as alpha-galactosylceramide and alpha-glucosylceramide; screening method to identify putative alpha-glycosylceramide molecules that can stimulate NKT cells through a CD1d mechanism; detecting a shift toward a Th1 response |
| 08/22/2002 | US20020115622 Therapeutic agent for mastitis of livestock and method for treating mastitis using the same agent |
| 08/22/2002 | US20020115621 Macrolide antibiotics |
| 08/22/2002 | US20020115620 6-0-carbamoyl ketolide antibacterials |
| 08/22/2002 | US20020115610 Isolated polypeptides that stimulate gastrointestinal smooth muscle contraction, including human; ionotropic agents; enhanced gastrointestinal motility; identifying a prokineticin receptor ligand; calcium mobilization |